Analysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO), Moderna (MRNA) and Monte Rosa Therapeutics (GLUE)
TipRanksMar 19 20:11
Allogene Therapeutics Analyst Ratings
BenzingaMar 19 18:53
Allogene Therapeutics Poised for Growth: A Strong Buy Rating Amidst Innovative Trials and Strategic Advancements
TipRanksMar 19 13:46
Allogene Therapeutics Analyst Ratings
BenzingaMar 16 00:17
RBC Capital Reiterates Outperform on Allogene Therapeutics, Maintains $10 Price Target
BenzingaMar 16 00:19
Allogene Therapeutics (ALLO) Gets a Buy From RBC Capital
TipRanksMar 15 18:47
Analysts Conflicted on These Healthcare Names: Allogene Therapeutics (ALLO), Aquestive Therapeutics (AQST) and Allakos (ALLK)
TipRanksMar 15 12:40
Analysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO) and Pliant Therapeutics (PLRX)
TipRanksMar 13 00:50
JP Morgan Maintains Overweight on Allogene Therapeutics, Lowers Price Target to $8
BenzingaFeb 28 02:18
Allogene Therapeutics Analyst Ratings
BenzingaFeb 28 02:17
HC Wainwright & Co. Maintains Buy on Allogene Therapeutics, Lowers Price Target to $10
BenzingaJan 19 19:38
Allogene Therapeutics Analyst Ratings
BenzingaJan 19 19:37
Strategic Shifts and Expansion Into Autoimmunity: A Buy Rating for Allogene Therapeutics
TipRanksJan 9 14:06
Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR) and Allogene Therapeutics (ALLO)
TipRanksJan 5 20:00
Allogene Therapeutics Analyst Ratings
BenzingaJan 5 19:25
JMP Securities Downgrades Allogene Therapeutics (ALLO) to a Hold
TipRanksJan 5 13:25
Buy Rating on Allogene Therapeutics Backed by Promising Clinical Data and Strategic Advancements
TipRanksDec 11, 2023 13:35
Citigroup Initiates Coverage On Allogene Therapeutics With Buy Rating, Announces Price Target of $7
BenzingaDec 8, 2023 20:53
Allogene Therapeutics Analyst Ratings
BenzingaDec 8, 2023 20:52
HC Wainwright & Co. Maintains Buy on Allogene Therapeutics, Lowers Price Target to $12
BenzingaNov 15, 2023 20:38
No Data
No Data